RIG-I antibody | knockout validation | Millipore MABF297

This is a knockout-validated antibody summary, based on the publication "Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

RIG-I antibody | knockout validation | Millipore MABF297 figure 1
Figure 1. Immunoblot of the indicated proteins in WT, RIG-I knockout, and RIG-I/TRIM25 (T25) double-knockout human A549 cells 24 h after infection with Udorn virus. Please see Figure 2a in the article [1].
Antibody information

Mouse monoclonal IgG1λ

Company: Millipore

Antibody: RIG-I

Catalog number: MABF297

Summary: Mouse monoclonal IgG1λ against recombinant protein corresponding to human RIG-I. Reacts with human by western blot, immunoprecipitation and immunocytochemistry.

Validation Method

Western blot

Sample

WT, RIG-I knockout, and RIG-I/TRIM25 double-knockout human A549 cells. Cells were lysed in 150 mM NaCl, 50 mM Tris-HCl (pH 7.4), 1% NP-40, 2.5 mM MgCl2, 5 mM EDTA, 10% glycerol, and supplemented with Complete protease inhibitor (Roche, #11836170001).

Blocking agent

TBST (0.1%) containing 3% nonfat dry milk for 30 minutes at room temperature.

Primary incubation

1:1,000 dilution diluted in TBST (0.1%) for 1 hr at room temperature.

Secondary incubation

1:10,000 dilution donkey anti-mouse horseradish peroxidase-conjugated (Thermo Scientific, #32430) diluted in TBST (0.1%) containing 3% nonfat dry milk for 40 minutes at room temperature.

Detection

ECL Plus detection reagent (GE Healthcare, #RPN2132).

References
  1. Meyerson N, Zhou L, Guo Y, Zhao C, Tao Y, Krug R, et al. Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation. Cell Host Microbe. 2017;22:627-638.e7 pubmed publisher